These diverse immune cells include CD8+ T cells, cancer-associated fibroblasts, M2 macrophages, neutrophils, and myeloid dendritic cells and T cell regulatory (Tregs), etc. Meantime, we performed Spearman correlation analysis (P< 0.01) on risk assessment and immune infiltrating cells (Figures 10C, D). This evidence concerns the gene CD8A and cancer.